Marubeni Acquires Stake in PT One-ject Indonesia, a Leading Manufacturer of Medical Consumables

Nov. 17, 2023
Marubeni Corporation

Marubeni Corporation (hereinafter, “Marubeni”), through its wholly-owned Singapore-based subsidiary Marubeni Growth Capital Asia Pte. Ltd. (hereinafter, “MGCA”) has invested in PT One-ject Indonesia (hereinafter, “Oneject”), a leading manufacturer of medical consumables in Indonesia.

Syringe manufactured by Oneject Syringe manufactured by Oneject

Demand for medical care in Southeast Asia is growing at an annual rate of approximately 8-10%, significantly higher than the characteristic rate seen in developed countries. This growth is being driven by rising incomes, an emerging middle-income population tier, and the low level of current spending on healthcare. In particular, demand for medical consumables, including syringes, is growing rapidly due to rising uptake of disposables in healthcare, driven by concerns around sanitization, the need for higher efficiency in operations, and adoption of international standards and practices.

Oneject is a dominant player in Auto-Disable Syringes (disposable syringes with a special safety mechanism to prevent re-use) in Indonesia, with its products meeting the standards specified by the World Health Organization and supplied to a number of international markets. 

There is an acute need for medical consumables manufacturers in the context of promoting self-sufficiency in medical devices and equipment. Oneject is accordingly expanding its manufacturing capabilities and knowledge with the aim of diversifying its portfolio to include adjacent product categories and consumables.

As a strategic, long-term business partner, MGCA is committed to supporting the development of Oneject's product portfolio, its international expansion, and its strategic goal of becoming a leading manufacturer of medical devices and consumables in Southeast Asia. This investment in Oneject represents MGCA’s first transaction in the healthcare sector in Southeast Asia, and its third investment overall.

Marubeni established the Next Generation Corporate Development Division in 2022 to capture the growth of consumer businesses in Southeast Asia and the United States, with the aim of thereby building a new consumer platform to drive Marubeni’s growth through 2030 and beyond.  Marubeni and MGCA remain committed to making further value-enhancing investments within the healthcare sector and supporting investee companies.

Marubeni Growth Capital Asia Pte. Ltd. Overview
Head Office: 8 Marina View, #14-03 Asia Square Tower 1, Singapore 018960
Representative: Bharat Sarma
Website: https://www.marubenigrowthcapital.com
Business Description: Investment in consumer related businesses in Southeast Asia focused on next generation consumers
PT One-ject Indonesia Overview
Head Office: Jalan Olympic Raya Kavling B-9, Sentul, Bogor, 16810, Indonesia
Representative: Jahja Tear Tjahjana
Website: https://oneject.co.id/
Business Description: Manufacture and sale of medical consumables and devices, and provision of services relating to medical equipment